Hidradenitis Suppurativa Market Research
What is Hidradenitis Suppurativa?
Hidradenitis Suppurativa (HS), also known as acne inversa, is an inflammatory skin condition causing painful abscesses to form under the skin. These abscesses occur in places where there are sweat glands, most commonly around the armpits, inner thighs, groin, buttocks and breasts. They develop as a result of blocked hair follicles.
In the U.S., it is estimated that approximately 1-2% of people suffer from HS. While there is no cure for HS, there are several treatment options available to help control the condition. Early treatment options include skincare plans and medications, but surgery may be required in more severe cases. If left untreated, the skin condition can worsen causing abscesses to break open and cause scarring.
Spherix Global Insights – Dermatology – Hidradenitis Suppurativa
Spherix Global Insights’ Dermatology therapeutic team is a leading provider of independent syndicated Hidradenitis Suppurativa market research, insights, business intelligence & advisory services.
Spherix’s Dermatology team covers studies publishing this year in their Market Dynamix™, Launch Dynamix™ and Patient Chart Dynamix™ services including:
- Market Dynamix™: Hidradenitis Suppurativa (US)
- Market Dynamix™: Hidradenitis Suppurativa (EU5)
- Launch Dynamix™: Cosentyx (Novartis) in Hidradenitis Suppurativa (US)*
- Patient Chart Dynamix™: Hidradenitis Suppurativa (US)
Spherix’s Market Dynamix™ service is based on dermatologists and key opinion leader feedback in the form of surveys and qualitative interviews. The reports consist of an analysis of markets anticipated to experience a paradigm shift within 3-5 years. Insights highlight market size, current treatment approaches, unmet needs, and expert opinions on the likely disruption introduced by pipeline agents.
Spherix’s Launch Dynamix™ service consists of two parts: monthly KPI tracking and quarterly deep dives. Monthly KPIs provide monthly benchmarking of newly launched products which includes for the first eighteen months of commercial availability, and quarterly deep dive reports includes promotional activity, barriers to uptake, and patient types gravitating to the launch brand.
Spherix’s Patient Chart Dynamix™ service includes patient level data detailing clinical and non-clinical patient demographics, along with rationale for treatment choices. It reveals real patient management patterns through rigorous analysis of large-scale patient chart audits.
Follow Spherix Dermatology on Social Media
Follow us for dermatology industry news, insights & analysis:
For Guests & Current Clients
For more details on Spherix’s primary market research reports and interactive dashboard offerings, visit or register here: https://clientportal.spherixglobalinsights.com